[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Citalopram Market - Global Outlook and Forecast 2021-2027

April 2021 | 113 pages | ID: C90E358CAE8BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Citalopram in Global, including the following market information:

Global Citalopram Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Citalopram market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Citalopram companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Citalopram Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Citalopram Market Segment Percentages, By Type, 2020 (%)
  • Solution
  • Tablets
  • Other
China Citalopram Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Citalopram Market Segment Percentages, By Application, 2020 (%)
  • Depression
  • Generalized Anxiety
  • Obsessive Compulsive Disorder
  • Somatoform Disorder
  • Schizophrenia
  • Other
Global Citalopram Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Citalopram Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Citalopram Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Citalopram Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • H.Lundbeck A/S
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • Hetero Drugs
  • Macleods Pharmaceuticals
  • Silarx Pharmacueticals
  • Apotex
  • Hikma Pharmaceuticals
  • Jubilant Pharma
  • Lupin Limited
  • Prinston Pharmaceutical
  • STI Pharma
  • TEVA Pharmaceutical
  • Hexal
  • Shanghai Great Wall Pharmaceutical
  • Wanquan Wante Pharmaceutical
  • Northeast Pharmaceutical Group
  • Sichuan Kelun Pharmaceutical
  • Kunming Jida Pharmaceutical
  • Jiangsu Enhua Pharmaceutical
  • Southwest Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Citalopram Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Citalopram Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CITALOPRAM OVERALL MARKET SIZE

2.1 Global Citalopram Market Size: 2021 VS 2027
2.2 Global Citalopram Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Citalopram Players in Global Market
3.2 Top Global Citalopram Companies Ranked by Revenue
3.3 Global Citalopram Revenue by Companies
3.4 Top 3 and Top 5 Citalopram Companies in Global Market, by Revenue in 2020
3.5 Global Companies Citalopram Product Type
3.6 Tier 1, Tier 2 and Tier 3 Citalopram Players in Global Market
  3.6.1 List of Global Tier 1 Citalopram Companies
  3.6.2 List of Global Tier 2 and Tier 3 Citalopram Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Citalopram Market Size Markets, 2021 & 2027
  4.1.2 Solution
  4.1.3 Tablets
  4.1.4 Other
4.2 By Type - Global Citalopram Revenue & Forecasts
  4.2.1 By Type - Global Citalopram Revenue, 2016-2021
  4.2.2 By Type - Global Citalopram Revenue, 2022-2027
  4.2.3 By Type - Global Citalopram Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Citalopram Market Size, 2021 & 2027
  5.1.2 Depression
  5.1.3 Generalized Anxiety
  5.1.4 Obsessive Compulsive Disorder
  5.1.5 Somatoform Disorder
  5.1.6 Schizophrenia
  5.1.7 Other
5.2 By Application - Global Citalopram Revenue & Forecasts
  5.2.1 By Application - Global Citalopram Revenue, 2016-2021
  5.2.2 By Application - Global Citalopram Revenue, 2022-2027
  5.2.3 By Application - Global Citalopram Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Citalopram Market Size, 2021 & 2027
6.2 By Region - Global Citalopram Revenue & Forecasts
  6.2.1 By Region - Global Citalopram Revenue, 2016-2021
  6.2.2 By Region - Global Citalopram Revenue, 2022-2027
  6.2.3 By Region - Global Citalopram Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Citalopram Revenue, 2016-2027
  6.3.2 US Citalopram Market Size, 2016-2027
  6.3.3 Canada Citalopram Market Size, 2016-2027
  6.3.4 Mexico Citalopram Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Citalopram Revenue, 2016-2027
  6.4.2 Germany Citalopram Market Size, 2016-2027
  6.4.3 France Citalopram Market Size, 2016-2027
  6.4.4 U.K. Citalopram Market Size, 2016-2027
  6.4.5 Italy Citalopram Market Size, 2016-2027
  6.4.6 Russia Citalopram Market Size, 2016-2027
  6.4.7 Nordic Countries Citalopram Market Size, 2016-2027
  6.4.8 Benelux Citalopram Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Citalopram Revenue, 2016-2027
  6.5.2 China Citalopram Market Size, 2016-2027
  6.5.3 Japan Citalopram Market Size, 2016-2027
  6.5.4 South Korea Citalopram Market Size, 2016-2027
  6.5.5 Southeast Asia Citalopram Market Size, 2016-2027
  6.5.6 India Citalopram Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Citalopram Revenue, 2016-2027
  6.6.2 Brazil Citalopram Market Size, 2016-2027
  6.6.3 Argentina Citalopram Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Citalopram Revenue, 2016-2027
  6.7.2 Turkey Citalopram Market Size, 2016-2027
  6.7.3 Israel Citalopram Market Size, 2016-2027
  6.7.4 Saudi Arabia Citalopram Market Size, 2016-2027
  6.7.5 UAE Citalopram Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 H.Lundbeck A/S
  7.1.1 H.Lundbeck A/S Corporate Summary
  7.1.2 H.Lundbeck A/S Business Overview
  7.1.3 H.Lundbeck A/S Citalopram Major Product Offerings
  7.1.4 H.Lundbeck A/S Citalopram Revenue in Global (2016-2021)
  7.1.5 H.Lundbeck A/S Key News
7.2 Amneal Pharmaceuticals
  7.2.1 Amneal Pharmaceuticals Corporate Summary
  7.2.2 Amneal Pharmaceuticals Business Overview
  7.2.3 Amneal Pharmaceuticals Citalopram Major Product Offerings
  7.2.4 Amneal Pharmaceuticals Citalopram Revenue in Global (2016-2021)
  7.2.5 Amneal Pharmaceuticals Key News
7.3 Aurobindo Pharma
  7.3.1 Aurobindo Pharma Corporate Summary
  7.3.2 Aurobindo Pharma Business Overview
  7.3.3 Aurobindo Pharma Citalopram Major Product Offerings
  7.3.4 Aurobindo Pharma Citalopram Revenue in Global (2016-2021)
  7.3.5 Aurobindo Pharma Key News
7.4 Hetero Drugs
  7.4.1 Hetero Drugs Corporate Summary
  7.4.2 Hetero Drugs Business Overview
  7.4.3 Hetero Drugs Citalopram Major Product Offerings
  7.4.4 Hetero Drugs Citalopram Revenue in Global (2016-2021)
  7.4.5 Hetero Drugs Key News
7.5 Macleods Pharmaceuticals
  7.5.1 Macleods Pharmaceuticals Corporate Summary
  7.5.2 Macleods Pharmaceuticals Business Overview
  7.5.3 Macleods Pharmaceuticals Citalopram Major Product Offerings
  7.5.4 Macleods Pharmaceuticals Citalopram Revenue in Global (2016-2021)
  7.5.5 Macleods Pharmaceuticals Key News
7.6 Silarx Pharmacueticals
  7.6.1 Silarx Pharmacueticals Corporate Summary
  7.6.2 Silarx Pharmacueticals Business Overview
  7.6.3 Silarx Pharmacueticals Citalopram Major Product Offerings
  7.6.4 Silarx Pharmacueticals Citalopram Revenue in Global (2016-2021)
  7.6.5 Silarx Pharmacueticals Key News
7.7 Apotex
  7.7.1 Apotex Corporate Summary
  7.7.2 Apotex Business Overview
  7.7.3 Apotex Citalopram Major Product Offerings
  7.4.4 Apotex Citalopram Revenue in Global (2016-2021)
  7.7.5 Apotex Key News
7.8 Hikma Pharmaceuticals
  7.8.1 Hikma Pharmaceuticals Corporate Summary
  7.8.2 Hikma Pharmaceuticals Business Overview
  7.8.3 Hikma Pharmaceuticals Citalopram Major Product Offerings
  7.8.4 Hikma Pharmaceuticals Citalopram Revenue in Global (2016-2021)
  7.8.5 Hikma Pharmaceuticals Key News
7.9 Jubilant Pharma
  7.9.1 Jubilant Pharma Corporate Summary
  7.9.2 Jubilant Pharma Business Overview
  7.9.3 Jubilant Pharma Citalopram Major Product Offerings
  7.9.4 Jubilant Pharma Citalopram Revenue in Global (2016-2021)
  7.9.5 Jubilant Pharma Key News
7.10 Lupin Limited
  7.10.1 Lupin Limited Corporate Summary
  7.10.2 Lupin Limited Business Overview
  7.10.3 Lupin Limited Citalopram Major Product Offerings
  7.10.4 Lupin Limited Citalopram Revenue in Global (2016-2021)
  7.10.5 Lupin Limited Key News
7.11 Prinston Pharmaceutical
  7.11.1 Prinston Pharmaceutical Corporate Summary
  7.11.2 Prinston Pharmaceutical Business Overview
  7.11.3 Prinston Pharmaceutical Citalopram Major Product Offerings
  7.11.4 Prinston Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.11.5 Prinston Pharmaceutical Key News
7.12 STI Pharma
  7.12.1 STI Pharma Corporate Summary
  7.12.2 STI Pharma Business Overview
  7.12.3 STI Pharma Citalopram Major Product Offerings
  7.12.4 STI Pharma Citalopram Revenue in Global (2016-2021)
  7.12.5 STI Pharma Key News
7.13 TEVA Pharmaceutical
  7.13.1 TEVA Pharmaceutical Corporate Summary
  7.13.2 TEVA Pharmaceutical Business Overview
  7.13.3 TEVA Pharmaceutical Citalopram Major Product Offerings
  7.13.4 TEVA Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.13.5 TEVA Pharmaceutical Key News
7.14 Hexal
  7.14.1 Hexal Corporate Summary
  7.14.2 Hexal Business Overview
  7.14.3 Hexal Citalopram Major Product Offerings
  7.14.4 Hexal Citalopram Revenue in Global (2016-2021)
  7.14.5 Hexal Key News
7.15 Shanghai Great Wall Pharmaceutical
  7.15.1 Shanghai Great Wall Pharmaceutical Corporate Summary
  7.15.2 Shanghai Great Wall Pharmaceutical Business Overview
  7.15.3 Shanghai Great Wall Pharmaceutical Citalopram Major Product Offerings
  7.15.4 Shanghai Great Wall Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.15.5 Shanghai Great Wall Pharmaceutical Key News
7.16 Wanquan Wante Pharmaceutical
  7.16.1 Wanquan Wante Pharmaceutical Corporate Summary
  7.16.2 Wanquan Wante Pharmaceutical Business Overview
  7.16.3 Wanquan Wante Pharmaceutical Citalopram Major Product Offerings
  7.16.4 Wanquan Wante Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.16.5 Wanquan Wante Pharmaceutical Key News
7.17 Northeast Pharmaceutical Group
  7.17.1 Northeast Pharmaceutical Group Corporate Summary
  7.17.2 Northeast Pharmaceutical Group Business Overview
  7.17.3 Northeast Pharmaceutical Group Citalopram Major Product Offerings
  7.17.4 Northeast Pharmaceutical Group Citalopram Revenue in Global (2016-2021)
  7.17.5 Northeast Pharmaceutical Group Key News
7.18 Sichuan Kelun Pharmaceutical
  7.18.1 Sichuan Kelun Pharmaceutical Corporate Summary
  7.18.2 Sichuan Kelun Pharmaceutical Business Overview
  7.18.3 Sichuan Kelun Pharmaceutical Citalopram Major Product Offerings
  7.18.4 Sichuan Kelun Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.18.5 Sichuan Kelun Pharmaceutical Key News
7.19 Kunming Jida Pharmaceutical
  7.19.1 Kunming Jida Pharmaceutical Corporate Summary
  7.19.2 Kunming Jida Pharmaceutical Business Overview
  7.19.3 Kunming Jida Pharmaceutical Citalopram Major Product Offerings
  7.19.4 Kunming Jida Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.19.5 Kunming Jida Pharmaceutical Key News
7.20 Jiangsu Enhua Pharmaceutical
  7.20.1 Jiangsu Enhua Pharmaceutical Corporate Summary
  7.20.2 Jiangsu Enhua Pharmaceutical Business Overview
  7.20.3 Jiangsu Enhua Pharmaceutical Citalopram Major Product Offerings
  7.20.4 Jiangsu Enhua Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.20.5 Jiangsu Enhua Pharmaceutical Key News
7.21 Southwest Pharmaceutical
  7.21.1 Southwest Pharmaceutical Corporate Summary
  7.21.2 Southwest Pharmaceutical Business Overview
  7.21.3 Southwest Pharmaceutical Citalopram Major Product Offerings
  7.21.4 Southwest Pharmaceutical Citalopram Revenue in Global (2016-2021)
  7.21.5 Southwest Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Citalopram Market Opportunities & Trends in Global Market
Table 2. Citalopram Market Drivers in Global Market
Table 3. Citalopram Market Restraints in Global Market
Table 4. Key Players of Citalopram in Global Market
Table 5. Top Citalopram Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Citalopram Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Citalopram Revenue Share by Companies, 2016-2021
Table 8. Global Companies Citalopram Product Type
Table 9. List of Global Tier 1 Citalopram Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Citalopram Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Citalopram Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Citalopram Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Citalopram Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Citalopram Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Citalopram Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Citalopram Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Citalopram Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Citalopram Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Citalopram Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Citalopram Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Citalopram Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Citalopram Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Citalopram Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Citalopram Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Citalopram Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Citalopram Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Citalopram Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Citalopram Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Citalopram Revenue, (US$, Mn), 2022-2027
Table 30. H.Lundbeck A/S Corporate Summary
Table 31. H.Lundbeck A/S Citalopram Product Offerings
Table 32. H.Lundbeck A/S Citalopram Revenue (US$, Mn), (2016-2021)
Table 33. Amneal Pharmaceuticals Corporate Summary
Table 34. Amneal Pharmaceuticals Citalopram Product Offerings
Table 35. Amneal Pharmaceuticals Citalopram Revenue (US$, Mn), (2016-2021)
Table 36. Aurobindo Pharma Corporate Summary
Table 37. Aurobindo Pharma Citalopram Product Offerings
Table 38. Aurobindo Pharma Citalopram Revenue (US$, Mn), (2016-2021)
Table 39. Hetero Drugs Corporate Summary
Table 40. Hetero Drugs Citalopram Product Offerings
Table 41. Hetero Drugs Citalopram Revenue (US$, Mn), (2016-2021)
Table 42. Macleods Pharmaceuticals Corporate Summary
Table 43. Macleods Pharmaceuticals Citalopram Product Offerings
Table 44. Macleods Pharmaceuticals Citalopram Revenue (US$, Mn), (2016-2021)
Table 45. Silarx Pharmacueticals Corporate Summary
Table 46. Silarx Pharmacueticals Citalopram Product Offerings
Table 47. Silarx Pharmacueticals Citalopram Revenue (US$, Mn), (2016-2021)
Table 48. Apotex Corporate Summary
Table 49. Apotex Citalopram Product Offerings
Table 50. Apotex Citalopram Revenue (US$, Mn), (2016-2021)
Table 51. Hikma Pharmaceuticals Corporate Summary
Table 52. Hikma Pharmaceuticals Citalopram Product Offerings
Table 53. Hikma Pharmaceuticals Citalopram Revenue (US$, Mn), (2016-2021)
Table 54. Jubilant Pharma Corporate Summary
Table 55. Jubilant Pharma Citalopram Product Offerings
Table 56. Jubilant Pharma Citalopram Revenue (US$, Mn), (2016-2021)
Table 57. Lupin Limited Corporate Summary
Table 58. Lupin Limited Citalopram Product Offerings
Table 59. Lupin Limited Citalopram Revenue (US$, Mn), (2016-2021)
Table 60. Prinston Pharmaceutical Corporate Summary
Table 61. Prinston Pharmaceutical Citalopram Product Offerings
Table 62. Prinston Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 63. STI Pharma Corporate Summary
Table 64. STI Pharma Citalopram Product Offerings
Table 65. STI Pharma Citalopram Revenue (US$, Mn), (2016-2021)
Table 66. TEVA Pharmaceutical Corporate Summary
Table 67. TEVA Pharmaceutical Citalopram Product Offerings
Table 68. TEVA Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 69. Hexal Corporate Summary
Table 70. Hexal Citalopram Product Offerings
Table 71. Hexal Citalopram Revenue (US$, Mn), (2016-2021)
Table 72. Shanghai Great Wall Pharmaceutical Corporate Summary
Table 73. Shanghai Great Wall Pharmaceutical Citalopram Product Offerings
Table 74. Shanghai Great Wall Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 75. Wanquan Wante Pharmaceutical Corporate Summary
Table 76. Wanquan Wante Pharmaceutical Citalopram Product Offerings
Table 77. Wanquan Wante Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 78. Northeast Pharmaceutical Group Corporate Summary
Table 79. Northeast Pharmaceutical Group Citalopram Product Offerings
Table 80. Northeast Pharmaceutical Group Citalopram Revenue (US$, Mn), (2016-2021)
Table 81. Sichuan Kelun Pharmaceutical Corporate Summary
Table 82. Sichuan Kelun Pharmaceutical Citalopram Product Offerings
Table 83. Sichuan Kelun Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 84. Kunming Jida Pharmaceutical Corporate Summary
Table 85. Kunming Jida Pharmaceutical Citalopram Product Offerings
Table 86. Kunming Jida Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 87. Jiangsu Enhua Pharmaceutical Corporate Summary
Table 88. Jiangsu Enhua Pharmaceutical Citalopram Product Offerings
Table 89. Jiangsu Enhua Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)
Table 90. Southwest Pharmaceutical Corporate Summary
Table 91. Southwest Pharmaceutical Citalopram Product Offerings
Table 92. Southwest Pharmaceutical Citalopram Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Citalopram Segment by Type
Figure 2. Citalopram Segment by Application
Figure 3. Global Citalopram Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Citalopram Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Citalopram Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Citalopram Revenue in 2020
Figure 8. By Type - Global Citalopram Revenue Market Share, 2016-2027
Figure 9. By Application - Global Citalopram Revenue Market Share, 2016-2027
Figure 10. By Region - Global Citalopram Revenue Market Share, 2016-2027
Figure 11. By Country - North America Citalopram Revenue Market Share, 2016-2027
Figure 12. US Citalopram Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Citalopram Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Citalopram Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Citalopram Revenue Market Share, 2016-2027
Figure 16. Germany Citalopram Revenue, (US$, Mn), 2016-2027
Figure 17. France Citalopram Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Citalopram Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Citalopram Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Citalopram Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Citalopram Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Citalopram Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Citalopram Revenue Market Share, 2016-2027
Figure 24. China Citalopram Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Citalopram Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Citalopram Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Citalopram Revenue, (US$, Mn), 2016-2027
Figure 28. India Citalopram Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Citalopram Revenue Market Share, 2016-2027
Figure 30. Brazil Citalopram Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Citalopram Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Citalopram Revenue Market Share, 2016-2027
Figure 33. Turkey Citalopram Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Citalopram Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Citalopram Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Citalopram Revenue, (US$, Mn), 2016-2027
Figure 37. H.Lundbeck A/S Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Amneal Pharmaceuticals Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Aurobindo Pharma Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Hetero Drugs Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Macleods Pharmaceuticals Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Silarx Pharmacueticals Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Apotex Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Hikma Pharmaceuticals Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Jubilant Pharma Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lupin Limited Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Prinston Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. STI Pharma Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. TEVA Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Hexal Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Shanghai Great Wall Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Wanquan Wante Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Northeast Pharmaceutical Group Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Sichuan Kelun Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Kunming Jida Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Jiangsu Enhua Pharmaceutical Citalopram Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications